Skip to Main Content

Paper Details

EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study.
J Pediatr Hematol Oncol
2
2018
Adenovirus, Alemtuzumab, CMV, CMV infection, EBV-PTLD, Epstein-Barr, Epstein-Barr virus posttransplant lymphoproliferative disorder, adenovirus, adenovirus infection, alemtuzumab, cytomegalovirus, graft-versus-host disease, hematopoietic stem cell, patient, pediatric, viral infections

Datasets

Release 1.2